Total Payments
$218,060
2024 Payments
$37,429
Companies
9
Transactions
212
Medicare Patients
298
Medicare Billing
$38,473
Payment Breakdown by Category
Other$100,961 (46.3%)
Travel$62,094 (28.5%)
Consulting$51,099 (23.4%)
Food & Beverage$3,835 (1.8%)
Education$69.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,961 | 36 | 46.3% |
| Travel and Lodging | $62,094 | 106 | 28.5% |
| Consulting Fee | $51,099 | 18 | 23.4% |
| Food and Beverage | $3,835 | 51 | 1.8% |
| Education | $69.99 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $118,906 | 114 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $81,580 | 68 | $0 (2023) |
| Astellas Pharma US Inc | $13,968 | 16 | $0 (2024) |
| Janssen Global Services, LLC | $2,480 | 1 | $0 (2019) |
| Melinta Therapeutics, LLC | $462.13 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $392.03 | 4 | $0 (2018) |
| Incyte Corporation | $128.26 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $73.44 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $69.74 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,429 | 24 | Merck Sharp & Dohme LLC ($36,827) |
| 2023 | $40,429 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($32,751) |
| 2022 | $60,165 | 54 | Takeda Pharmaceuticals U.S.A., Inc. ($48,829) |
| 2021 | $3,652 | 3 | Astellas Pharma US Inc ($2,677) |
| 2020 | $2,490 | 2 | Merck Sharp & Dohme Corporation ($2,275) |
| 2019 | $24,857 | 40 | Merck Sharp & Dohme Corporation ($22,356) |
| 2018 | $30,338 | 35 | Merck Sharp & Dohme Corporation ($30,075) |
| 2017 | $18,699 | 23 | Merck Sharp & Dohme Corporation ($18,423) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $73.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/19/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $43.69 | General |
| 06/24/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $128.26 | General |
| Category: Hematology/Oncology | ||||||
| 05/22/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $100.57 | General |
| Category: ANTIFUNGALS | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,627.50 | General |
| 05/07/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Consulting Fee | Cash or cash equivalent | $256.50 | General |
| Category: Infectious Diseases | ||||||
| 04/17/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,580.00 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,255.00 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/13/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $400.00 | General |
| 04/12/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $8,500.00 | General |
| 04/12/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $170.00 | General |
| 02/26/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,580.00 | General |
| 02/26/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 02/08/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $232.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/07/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $238.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/06/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $238.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/05/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $238.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/04/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $238.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/04/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $140.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/04/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $94.69 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/03/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $9,625.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/03/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Travel and Lodging | In-kind items and services | $218.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/30/2023 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $135.22 | General |
| Category: ANTIFUNGALS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 54 | $30,796 | $7,076 |
| 2022 | 3 | 44 | 56 | $21,749 | $6,423 |
| 2021 | 5 | 80 | 105 | $34,105 | $10,156 |
| 2020 | 5 | 123 | 190 | $48,406 | $14,819 |
Total Patients
298
Total Services
405
Medicare Billing
$38,473
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $23,415 | $5,380 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 17 | $7,381 | $1,696 | 23.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $8,338 | $2,345 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $7,267 | $2,056 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 24 | $6,144 | $2,023 | 32.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 33 | $8,943 | $2,855 | 31.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 24 | $9,690 | $2,816 | 29.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $7,742 | $2,248 | 29.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 22 | $3,674 | $1,292 | 35.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 13 | 13 | $4,056 | $944.32 | 23.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 33 | 86 | $16,598 | $5,482 | 33.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 44 | 44 | $17,764 | $5,323 | 30.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 25 | $6,775 | $2,285 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 16 | $4,096 | $966.00 | 23.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 19 | $3,173 | $763.56 | 24.1% |
About Dr. Sanjeet Dadwal, MD
Dr. Sanjeet Dadwal, MD is a Internal Medicine healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669589537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjeet Dadwal, MD has received a total of $218,060 in payments from pharmaceutical and medical device companies, with $37,429 received in 2024. These payments were reported across 212 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,961).
As a Medicare-enrolled provider, Dadwal has provided services to 298 Medicare beneficiaries, totaling 405 services with total Medicare billing of $38,473. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Duarte, CA
- Active Since 08/24/2006
- Last Updated 12/04/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669589537
Products in Payments
- LIVTENCITY (Drug) $76,830
- PREVYMIS (Drug) $40,902
- Cresemba (Drug) $10,985
- CRESEMBA (Drug) $2,913
- Rezzayo (Drug) $385.64
- JAKAFI (Drug) $128.26
- ZERBAXA (Drug) $73.65
- REBYOTA (Biological) $73.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Duarte
Amrita Krishnan, Md, MD
Internal Medicine — Payments: $841,332
Internal Medicine $841,332
Dr. Daneng Li, M.d, M.D
Internal Medicine — Payments: $584,406
Internal Medicine $584,406
Alexey Danilov, M.d, M.D
Internal Medicine — Payments: $419,324
Internal Medicine $419,324
Marwan Fakih, Md, MD
Internal Medicine — Payments: $355,683
Internal Medicine $355,683
Dr. Tycel Phillips, M.d, M.D
Internal Medicine — Payments: $336,879
Internal Medicine $336,879
Haris Ali, M.d, M.D
Internal Medicine — Payments: $293,846
Internal Medicine $293,846